New hope for the treatment of corona virus patients, after the French company Sanofi announced the treatment of the first patient with treatment Kevzara.
The drug is an immunotherapy intended for the treatment of rheumatoid arthritis patients, and experiments were conducted in more than 7 countries to ensure its effectiveness for the treatment of corona patients, as clinical trials have now begun in Italy, Spain, Germany, France, Canada, Russia and America and the most important results of the drug’s success in reducing fever for 21 patients in The first experiments, as he succeeded in getting 75% of patients out of the experiment from a respirator.
– .
Related posts:
Yousra's health status developments (video)
Research indicates youth smoke More than half of "E-cigarettes-marijuana extracts" suffer from anxi...
554 residents of the city of Bekasi HIV / AIDS positive throughout 2022
"We are not going to continue changing the laws if the laboratory does not give the agreement"
